drugset / Trial / NCT05157139
Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease
Phase 2/3
Unknown
120 enrolled
Alexandria University
Assoc. Prof. Ayman Ibrahim Baess · collabDr. Noha Alaa Eldine Hassan Hamdy · collabPh. Hanya Hesham Sweilam · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
* The study is a randomized clinical trial to assess a natural formula of vanillin \& wheat germ oil to treat and stop the clinical progression of COVID-19. * The study aims to treat people with mild-to-moderate COVID-19 before their cases become severe. * The study duration is a 5-day experimental intervention and an extended 4 weeks follow up.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2022-03
- Completion
- 2022-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | vanillin | Small molecule | 1 unknown | Oral |
| Comparator | wheat germ oil | Unknown | 1 unknown | Oral |
Indications
No indication recorded.